Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.393, Iss.1, 2000-03, pp. : 165-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 1986-1997

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric modulation of muscarinic acetylcholine receptors

By Tucek S. Proska J.

Trends in Pharmacological Sciences, Vol. 16, Iss. 6, 1995-06 ,pp. : 205-212

Elsevier

Access to resources Recommend Favorite

Allosteric Modulation of Muscarinic Acetylcholine Receptors

Current Neuropharmacology, Vol. 5, Iss. 3, 2007-09 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Neuroprotective, Neurotrophic or Both?

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite

The anthelmintic levamisole is an allosteric modulator of human neuronal nicotinic acetylcholine receptors

By Levandoski M.M. Piket B. Chang J.

European Journal of Pharmacology, Vol. 471, Iss. 1, 2003-06 ,pp. : 9-20

Elsevier

Access to resources Recommend Favorite